Lv1
40 积分 2022-04-14 加入
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
10小时前
待确认
Monoclonal Antibodies: A Review
11小时前
已完结
Reversal of Autoimmune Toxicity and Loss of Tumor Response by Interleukin-17 Blockade
22天前
已完结
Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer
22天前
已完结
IL-17A functions and the therapeutic use of IL-17A and IL-17RA targeted antibodies for cancer treatment
22天前
已完结
IL-17RA signaling provides dual tumor-suppressor function during late-stage colorectal carcinogenesis
22天前
已完结
Psoriatic Arthritis
1个月前
已完结
Comparative Effectiveness of Ixekizumab Versus Ustekinumab in Patients With Psoriasis: A Randomized Controlled Trial Replication Using Data From an Observational Study (Shanghai Psoriasis Effectiveness Evaluation Cohort)
2个月前
已完结
Prevalence of ankylosing spondylitis in a Chinese population: a systematic review and meta-analysis
2个月前
已完结
Axial spondyloarthritis
2个月前
已完结
皖公网安备34019202002308
